Cargando…
A randomized clinical trial evaluating the effect of empagliflozin on triglycerides in obese adults: Role of visceral fat
BACKGROUND: Empagliflozin, a sodium glucose cotransporter 2 inhibitor, is a medication to treat type 2 diabetes. The effect of empagliflozin in persons without diabetes has received less attention. Here we conducted a randomized, double-blind placebo-controlled clinical trial to examine the effect o...
Autores principales: | Lee, Min Hee, Neeland, Ian J., de Albuquerque Rocha, Natalia, Hughes, Connor, Malloy, Craig R., Jin, Eunsook S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728102/ https://www.ncbi.nlm.nih.gov/pubmed/35024596 http://dx.doi.org/10.1016/j.metop.2021.100161 |
Ejemplares similares
-
Serum Triglyceride Levels Independently Contribute to the Estimation of Visceral Fat Amount Among Nondiabetic Obese Adults
por: Huang, Chiao-Yu, et al.
Publicado: (2015) -
Influence of Liver Triglycerides on Suppression of Glucose Production by Insulin in Men
por: Jin, Eunsook S., et al.
Publicado: (2015) -
The effect of thalidomide on visceral fat pad mass and triglyceride concentration of the skeletal muscles in rats
por: Kim, Ki-Hoon, et al.
Publicado: (2018) -
Divergent effects of glutathione depletion on isocitrate dehydrogenase 1 and the pentose phosphate pathway in hamster liver
por: Jin, Eunsook S., et al.
Publicado: (2020) -
The presence of 3-hydroxypropionate and 1,3-propanediol suggests an alternative path for conversion of glycerol to Acetyl-CoA
por: Jin, Eunsook S., et al.
Publicado: (2021)